Clinical implications of fatty pancreas: Correlations between fatty pancreas and metabolic syndrome

World Journal of Gastroenterology

Volumn 15, Issue 15, 2009, Pages 1869-1875

  Lee, Jun Seok ^a   Kim, Sang Heum ^a   Jun, Dae Won ^a   Han, Jee Hye ^a   Jang, Eun Chul ^b   Park, Ji Young ^a   Son, Byung Kwan ^a   Kim, Seong Hwan ^a   Jo, Yoon Ju ^a   Park, Young Sook ^a   Kim, Yong Soo ^c  

^a Eulji University School of Medicine   (South Korea)

^b Soonchunhyang University   (South Korea)

^c Hanyang University   (South Korea)

Author keywords

Fatty pancreas; Insulin resistance; Metabolic syndrome

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CHOLESTEROL; FATTY ACID; GAMMA GLUTAMYLTRANSFERASE; GLUCOSE; HIGH DENSITY LIPOPROTEIN; INSULIN; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ADULT; AGE; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BODY MASS; CHOLESTEROL BLOOD LEVEL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISEASE CLASSIFICATION; ECHOGRAPHY; FATTY ACID BLOOD LEVEL; FATTY PANCREAS; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GLUCOSE BLOOD LEVEL; HOMEOSTASIS; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INTRAABDOMINAL FAT; LIPID STORAGE; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PANCREAS DISEASE; RETROPERITONEAL FAT; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE;

ADULT; ANIMALS; FATTY LIVER; FEMALE; HUMANS; INSULIN RESISTANCE; INTRA-ABDOMINAL FAT; LIPID METABOLISM; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PANCREAS; PANCREATIC DISEASES; REGRESSION ANALYSIS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 67651241512     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.15.1869     Document Type: Article

References (22)

1. Yin W, Liao D, Kusunoki M, Xi S, Tsutsumi K, Wang Z, Lian X, Koike T, Fan J, Yang Y, Tang C. NO-1886 decreases ectopic lipid deposition and protects pancreatic beta cells in diet-induced diabetic swine. J Endocrinol 2004; 180: 399-408
2. Gullo L. Benign pancreatic hyperenzymemia or Gullo's syndrome. JOP 2006; 7: 241-242; author reply 243-244
3. Nghiem DD, Olson PR, Ormond D. The "fatty pancreas allograft": anatomopathologic findings and clinical experience. Transplant Proc 2004; 36: 1045-1047
4. Tham RT, Heyerman HG, Falke TH, Zwinderman AH, Bloem JL, Bakker W, Lamers CB. Cystic fibrosis: MR imaging of the pancreas. Radiology 1991; 179: 183-186
5. Ferrozzi F, Bova D, Campodonico F, De Chiara F, Uccelli M, Bacchini E, Grinzcich R, dè Angelis GL, Battistini A. Cystic fibrosis: MR assessment of pancreatic damage. Radiology 1996; 198: 875-879
6. Marks WM, Filly RA, Callen PW. Ultrasonic evaluation of normal pancreatic echogenicity and its relationship to fat deposition. Radiology 1980; 137: 475-479
7. Glaser J, Stienecker K. Pancreas and aging: a study using ultrasonography. Gerontology 2000; 46: 93-96
8. Lee Y, Hirose H, Ohneda M, Johnson JH, McGarry JD, Unger RH. Beta-cell lipotoxicity in the pathogenesis of non-insulin-dependent diabetes mellitus of obese rats: impairment in adipocyte-beta-cell relationships. Proc Natl Acad Sci USA 1994; 91: 10878-10882
9. Hirose H, Lee YH, Inman LR, Nagasawa Y, Johnson JH, Unger RH. Defective fatty acid-mediated beta-cell compensation in Zucker diabetic fatty rats. Pathogenic implications for obesity-dependent diabetes. J Biol Chem 1996; 271: 5633-5637
10. Milburn JL Jr, Hirose H, Lee YH, Nagasawa Y, Ogawa A, Ohneda M, BeltrandelRio H, Newgard CB, Johnson JH, Unger RH. Pancreatic beta-cells in obesity. Evidence for induction of functional, morphologic, and metabolic abnormalities by increased long chain fatty acids. J Biol Chem 1995; 270: 1295-1299
11. Gulcan E, Gulcan A, Ozbek O. Is there a role of pancreatic steatosis together with hypertrigliceridemia on the pathogenesis of diabetes in a patient with type 2 diabetes mellitus? Med Hypotheses 2007; 68: 912-913
12. Gullo L, Salizzoni E, Serra C, Calculli L, Bastagli L, Migliori M. Can pancreatic steatosis explain the finding of pancreatic hyperenzymemia in subjects with dyslipidemia? Pancreas 2006; 33: 351-353
13. Wallace TM, Levy JC, Matthews DR. Use and abuse of HOMA modeling. Diabetes Care 2004; 27: 1487-1495
14. Worthen NJ, Beabeau D. Normal pancreatic echogenicity: relation to age and body fat. AJR Am J Roentgenol 1982; 139: 1095-1098
15. Piekarski J, Goldberg HI, Royal SA, Axel L, Moss AA. Difference between liver and spleen CT numbers in the normal adult: its usefulness in predicting the presence of diffuse liver disease. Radiology 1980; 137: 727-729
16. Quinn SF, Gosink BB. Characteristic sonographic signs of hepatic fatty infiltration. AJR Am J Roentgenol 1985; 145: 753-755
17. Chalasani N, Deeg MA, Persohn S, Crabb DW. Metabolic and anthropometric evaluation of insulin resistance in nondiabetic patients with nonalcoholic steatohepatitis. Am J Gastroenterol 2003; 98: 1849-1855
18. Marchesini G, Brizi M, Morselli-Labate AM, Bianchi G, Bugianesi E, McCullough AJ, Forlani G, Melchionda N. Association of nonalcoholic fatty liver disease with insulin resistance. Am J Med 1999; 107: 450-455
19. Noronha M, Salgadinho A, Ferreira De Almeida MJ, Dreiling DA, Bordalo O. Alcohol and the pancreas. I. Clinical associations and histopathology of minimal pancreatic inflammation. Am J Gastroenterol 1981; 76: 114-119
20. Isserow JA, Siegelman ES, Mammone J. Focal fatty infiltration of the pancreas: MR characterization with chemical shift imaging. AJR Am J Roentgenol 1999; 173: 1263-1265
21. Heuck A, Maubach PA, Reiser M, Feuerbach S, Allgayer B, Lukas P, Kahn T. Age-related morphology of the normal pancreas on computed tomography. Gastrointest Radiol 1987; 12: 18-22
22. Alzaid A, Aideyan O, Nawaz S. The size of the pancreas in diabetes mellitus. Diabet Med 1993; 10: 759-763